212 related articles for article (PubMed ID: 31890743)
1. Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease.
Chen C; Guderyon MJ; Li Y; Ge G; Bhattacharjee A; Ballard C; He Z; Masliah E; Clark RA; O'Connor JC; Li S
Mol Ther Methods Clin Dev; 2020 Jun; 17():83-98. PubMed ID: 31890743
[TBL] [Abstract][Full Text] [Related]
2. GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.
Chen C; Li X; Ge G; Liu J; Biju KC; Laing SD; Qian Y; Ballard C; He Z; Masliah E; Clark RA; O'Connor JC; Li S
Sci Rep; 2018 Apr; 8(1):5460. PubMed ID: 29615705
[TBL] [Abstract][Full Text] [Related]
3. Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease.
Ge G; Chen C; Guderyon MJ; Liu J; He Z; Yu Y; Clark RA; Li S
Stem Cells Dev; 2018 Jul; 27(14):995-1005. PubMed ID: 29562865
[TBL] [Abstract][Full Text] [Related]
4. Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson's disease.
Ge G; Sivasubramanian BP; Geng BD; Zhao S; Zhou Q; Huang G; O'Connor JC; Clark RA; Li S
Gene Ther; 2024 May; 31(5-6):324-334. PubMed ID: 38627469
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.
Biju K; Zhou Q; Li G; Imam SZ; Roberts JL; Morgan WW; Clark RA; Li S
Mol Ther; 2010 Aug; 18(8):1536-44. PubMed ID: 20531393
[TBL] [Abstract][Full Text] [Related]
6. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
Connor B
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Biju KC; Santacruz RA; Chen C; Zhou Q; Yao J; Rohrabaugh SL; Clark RA; Roberts JL; Phillips KA; Imam SZ; Li S
Neurosci Lett; 2013 Feb; 535():24-9. PubMed ID: 23295906
[TBL] [Abstract][Full Text] [Related]
10. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
[TBL] [Abstract][Full Text] [Related]
12. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
[TBL] [Abstract][Full Text] [Related]
13. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
Jaumotte JD; Zigmond MJ
J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
Ucar B; Humpel C
Brain Res Bull; 2019 Jul; 149():86-95. PubMed ID: 31004735
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
17. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
18. Protection of nigral neurons by GDNF-engineered marrow cell transplantation.
Park KW; Eglitis MA; Mouradian MM
Neurosci Res; 2001 Aug; 40(4):315-23. PubMed ID: 11463477
[TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P
Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933
[TBL] [Abstract][Full Text] [Related]
20. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.
Bäckman CM; Shan L; Zhang YJ; Hoffer BJ; Leonard S; Troncoso JC; Vonsatel P; Tomac AC
Mol Cell Endocrinol; 2006 Jun; 252(1-2):160-6. PubMed ID: 16644101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
